Press Releases

Press Releases

May 08, 2019
GAITHERSBURG, Md. , May 08, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced it will effect a one-for-twenty reverse stock split of its issued and outstanding common stock. Stockholders of Novavax approved an amendment to Novavax’ Second Amended and Restated Certificate of...
May 02, 2019
             Company to Host Conference Call Today at 4:30 p.m. ET GAITHERSBURG, Md. , May 02, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq: NVAX) today announced its financial results and operational highlights for the first quarter ended March 31, 2019 ....
Mar 18, 2019
Company to Host Conference Call Today at 4:30 p.m. ET GAITHERSBURG, Md. , March 18, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth quarter and twelve months ended December 31, 2018 ....
Jan 03, 2019
Sets the Stage for Phase 3 Clinical Trial in 2019 Phase 2 clinical trial confirmed Phase 1/2 results, again demonstrating improved immune responses over Fluzone ® High-Dose End-of-Phase 2 meeting with the FDA expected in the first half of 2019 Pivotal Phase 3 clinical trial expected to initiate in...
Jan 02, 2019
GAITHERSBURG, Md. , Jan. 02, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will present at the 37th Annual J.P. Morgan Healthcare Conference . Presentation details are as follows: Date and time: Wednesday, January 9 , 3:00 p.m. – 3:25 p.m. P.T....
Displaying 51 - 60 of 180